Sound waves may wake up immune system against liver tumors
NCT ID NCT07365527
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using ultrasound with a contrast agent (sonoporation) can change the environment inside liver tumors that have spread from colorectal cancer. 48 adults will be randomly assigned to receive either low- or high-intensity ultrasound, or no ultrasound. The goal is to see if this procedure can make the tumor more welcoming to immune cells, potentially boosting future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
contrast-enhanced ultrasound (SonoVue)
What this could lead to
If it works, this could point toward a way to make liver tumors more responsive to the body's own immune system.
What could go wrong
This is a very early, small study (48 people) testing safety and biological effects, not treatment success. It may not lead to any direct benefit for patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASES FROM COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rigshospitalet
RECRUITINGCopenhagen, 2100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Surgical Department, Zealand University Hospital
RECRUITINGKøge, 4600, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••